The pRb family proteins (pRb1/105, p107, pRb2/p130), collectively referred to as pocket proteins, are believed to function primarily as regulators of the mammalian cell cycle progression, and suppressors of cellular growth and proliferation. In addition, different studies suggest that these pocket proteins are also involved in development and differentiation of various tissues. Several lines of evidence indicate that generally pRb-family proteins function through their effect on the transcription of E2F-regulated genes. In fact, each of Rb family proteins binds to distinct members of the E2F transcription factors, which regulate the expression of genes whose protein products are necessary for cell proliferation and to drive cell-cycle progression. Nevertheless, pocket proteins can affect the G1/S transition through E2F-independent mechanisms. More recently, a broad range of evidences indicate that pRb-family proteins associate with a wide variety of transcription factors and chromatin remodeling enzymes forming transcriptional repressor complexes that control gene expression. This review focuses on the complex regulatory mechanisms by which pRb-family proteins tell genes when to switch on and off.
Introduction pRb1/105, p107 and pRb2/p130 constitute a small family of nuclear proteins, collectively referred to as pocket proteins and believed to function primarily as regulators of the mammalian cell cycle progression, and suppressors of cellular growth and proliferation (Balciunaite et al., 2005) . Moreover, different studies suggest that these pocket proteins are also involved in development and differentiation of various tissues (Puri et al., 2001; Wikenheiser-Brokamp, 2004; Nguyen and McCance, 2005) .
Our studies and work from others have shown that the Rb family proteins exhibit a different expression pattern at various stages of the cell cycle in different tissues, and indicated that the functional overlap among these proteins does not extend to a complete redundancy (Baldi et al., 1997; Galderisi et al., 2001; Ruiz et al., 2004; Spencer et al., 2005) . Also, the three pocket proteins are regulated by cyclic events, such as phosphorylation/dephosphorylation and nuclear compartmentalization during cell cycle progression (Gallo and Giordano, 2005 , see also Soprano et al., in this issue). Precisely how pRb-family proteins regulate cell proliferation is not completely understood. Nevertheless, several lines of evidence indicate that generally pRb-family proteins function through their effect on the transcription of genes regulated by the E2F proteins. Each of the Rb family proteins binds to distinct members of the E2F transcription factors, which regulate the expression of genes whose protein products are necessary for cell proliferation and to drive cell-cycle progression (Muller et al., 2001; Young et al., 2003; Attwooll et al., 2004) . More recently a broad range of studies are showing that pRb-family proteins associate with a wide variety of transcription factors and chromatin remodeling enzymes to control gene expression (La Sala et al., 2003; Macaluso et al., 2003 Macaluso et al., , 2005 Macaluso et al., , 2006 Gunawardena et al., 2004; Parakati and DiMario, 2005) .
Interplay between pocket proteins and E2F transcription factors in the regulation of E2F-responsive genes
The most well described molecular characteristic of pRb-family proteins (pRb1/p105, pRb2/p130 and p107) is their common ability to interact with the E2F family of transcription factors, which comprise a group of at least seven DN-binding proteins (E2F1-E2F7) and the DP1 and DP-binding partners of E2F-E2F6 (Paggi and Giordano, 2001; Dimova and Dyson, 2005; Tsantoulis and Gorgoulis, 2005) . Different studies have been suggested that E2Fs factors can function both as activator and repressor of transcription (Dimova and Dyson, 2005; Tsantoulis and Gorgoulis, 2005) . It has been shown that among the E2F family, E2F1, E2F2 and E2F3a act as strong transcriptional activators, while E2F3b, E2F4, E2F5, E2F6 and E2F7 exhibit transcriptional repressor functions (Attwooll et al., 2004; Cobrinik, 2005) .
Nevertheless, each of the Rb family proteins bind to distinct members of the E2F transcription factors, which regulate the expression of genes whose protein products are necessary for cell cycle progression, DNA repair, apoptosis, differentiation and development (Galderisi et al., 2001; Muller et al, 2001; Polager et al., 2002; Ren et al, 2002; Caputi et al., 2005; Cobrinik, 2005) . pRb1/ p105 preferentially binds to the activators E2Fs, E2F1, E2F2, E2F3a, as well as E2F3b, which may function mainly as a repressor (Claudio et al., 2002; Trimarchi and Lees, 2002; Leone et al, 2000) . pRb2/p130 and p107 preferentially bind the repressor E2Fs, E2F4 and E2F5 (Hijmans et al., 1995; Dyson, 1998; Claudio et al., 2002; Farkas et al., 2002) . E2F6 and E2F 7 do not bind pocket proteins and form pocket protein-independent repressor complexes (Trimarchi and Lees, 2002; Aslanian et al., 2004; Ginsberg, 2004) .
During G0 and early G1, the activity of E2Fs is mainly maintained by E2F4 and E2F5, which are bound preferentially to pRb2/p130 exerting an inhibitory effect on the E2F-responsive genes. pRb2/p130, in association with E2F-4, is the most abundant E2F complex found in differentiated or quiescent cells in G0, and this complex is thought to help maintain a state of transcriptional silence (Claudio et al., 2002) . As the cells start to reenter the cell cycle, E2F-4 is still found in association with pRb2/p130 in early G1. pRb2/p130 is then replaced by p107 in mid to late G1 and then by pRb/p105 in the late G1-and S-phases ( Figure 1 ) (Kato et al., 1993; Ginsberg et al., 1994; Moberg et al., 1996; Lundberg and Weinberg, 1998) . The abundance of pRb-E2F complexes is regulated not only by the phosphorylation of the pocket proteins, but also by the levels of both component proteins. Whereas pRb1/p105 is commonly expressed in both proliferating and nonproliferating cells, pRb2/130 is most prominent in arrested cells and p107 is prominent in proliferating cells. E2F1, E2F2 and E2F3a are expressed at high levels and stimulate gene expression in late G1, whereas are generally absent or expressed at low levels in quiescent cells (Dyson, 1998) . E2F3b is expressed throughout the cell cycle and forms transcriptional repressor complexes with pRb/105 in G0 and pockets protein-independent repressor complexes in both resting and proliferating cells (Leone et al., 2000; Aslanian et al., 2004; Ginsberg, 2004) . E2F4 and E2F5, which lack of a nuclear localization signal, are expressed throughout the cell cycle, but in G0 and early G1 they are bound and recruited to the nucleus by pRb2/p130 and p107 forming transcriptional repressor complexes at most of E2F-responsive promoters (Dimova and Dyson, 2005; Macaluso et al., 2005 Macaluso et al., , 2006 . Interestingly, it has been reported that, at some promoters, E2F1-E2F3 may bind to sites different from those vacated by E2F4 and E2F5 (Araki et al., 2003; Zhu et al., 2004; Cobrinik, 2005) . It remains to elucidate whether E2F1-E2F3 and pRb1/p105 participate in promoter repression in G0 and early G1. However, it has been suggested that pRb1/ p105 directly participates in the repression of only a limited set of E2F-responsive genes in G0 and early G1 (Morrison et al., 2002; Rayman et al., 2002) . The phosphorylation status of each of the Rb family members varies throughout the cell cycle. The best candidates for the phosphorylation of pRb/p105 and p107 are the cyclin D1-cdk4/6 complexes Paggi et al., 1996; Lundberg and Figure 1 Model for the regulation of gene expression by pocket proteins, E2F transcription factors and chromatin modifiers. E2Fs/ pocket proteins/chromatin modifiers (histone deacetylase, HDAC, histone methyltransferase, SUV39H1) are present at cell cycleregulated promoters in G0 and early G1 and function to repress transcription (Additional components of the complexes have been omitted for clarity). During G0 and early G1, the activity of E2Fs is mainly maintained by E2F4 and E2F5, which are bound preferentially to pRb2/p130 exerting an inhibitory effect on the E2F-responsive genes. pRb2/p130 is then replaced by p107 in mid to late G1 and then by pRb/p105 in the late G1-and S-phases. Upon mitogenic stimulation G1, CDKs phosphorilate pocket proteins and disrupt E2Fs/pocket proteins interaction. Switching from 'repressive' to 'activating' E2Fs and the recruitment of histone acetyltransferase activity allows G1-to S-phase transition.
Pocket proteins: modulators of gene transcription M Macaluso et al 1998). In vitro studies indicate that cyclin D3/cdk4 complexes use pRb2/p130 as a substrate (Dong et al., 1998) . Unlike pRb/p105, both p107 and pRb2/p130 form stable complexes with cyclin A-cdk2 and cyclin E-cdk2 complexes (Hannon et al., 1993; Li et al., 1993; Zhu et al., 1993; Claudio et al., 1996) . Interestingly, p107 and pRb2/p130 contain a p21-like kinase inhibitory domain that has been shown to inhibit cdk2 kinase activity in vivo for p107 (Zhu et al., 1995; Woo et al., 1997) and in vitro for pRb2/p130 Woo et al., 1997) . Additionally, in pRb2/p130 a distinct kinase inhibitory domain is located within the spacer region that specifically inhibits cdk2 kinase activity in vitro (De Luca et al., 1997). The E2F-responsive genes are generally regulated in G0/G1 through the interaction between E2Fs and pocket proteins. However, different studies indicated that the functional overlap among pocket proteins does not extend to a complete redundancy, indicating a complex network of interactions between E2Fs and pRb family proteins. (Claudio et al., 2002; Galderisi et al., 2001; Black et al 2003; Spencer et al., 2005) . Indeed, most of E2F-responsive genes are deregulated in p107/ pRb2/p130-deficient cells (Mulligan et al., 1998; Ren et al., 2002; Cam and Dynlacht, 2003) . Moreover, Black et al. (2003) reported that an overlapping set of genes were deregulated in pRb1/p105-deficient versus p107/ pRb2/p130-deficient cells. Until now, the features dictating whether a promoter is deregulated by loss of a specific pocket proteins, have not been define. In addition, whereas the pocket proteins appear do not regulate the E2F-responsive genes in a fully redundant manner, these proteins show functional redundancy and compensation at cell cycle level. In fact, it has been reported that fibroblasts lacking either pRb1/p105 or p107/pRb2/p130 maintain the ability to arrest in G0/G1 with respect to fibroblasts lacking all three pocket proteins (Dannenberg et al., 2000; Sage et al., 2000. However, the redundancy and compensation among the pocket proteins observed in mouse fibroblasts in vitro fail to do so in a number of cell types in vivo (Marino et al., 2003; Chen et al., 2004; Ruiz et al., 2004; Wikenheiser-Brokamp, 2004 ).
More recently, it has indicated that pocket proteins not only inhibit E2F-mediated transactivation but also function together with the E2Fs to actively repress trancription and inhibit G1/S progression, by governing the expression of genes that control entry into and progression through mitosis (Zhang et al., 1999; He et al., 2000; Ishida et al., 2001; Hsu et al., 2002; Dimova et al., 2003) . In addition, it has been suggested that pocket proteins regulate G1/S-transition through E2F-independent mechanisms. For instance, p107 and pRb2/ 130, but not pRb1/p105, bind and inhibit the cyclin E/Cdk2 and cyclin A/Cdk2 kinases, exerting an activity that is mechanistically similar to that of Cdk inhibitors (CKIs) (Zhu et al., 1995) . Moreover, it has been reported that pRb1/p105 has E2F-independent function by which it inhibits proliferation. pRrb1/p105 inhibits Cdk activity and G1-S progression by increasing the expression of p27 (Ji et al., 2004) , can induce the formation of PML nuclear bodies (Fang et al., 2002) , can also suppress Ras signaling and augment expression of differentiation-associated genes (Sellers et al., 1998; Lee et al., 1999; Thomas et al., 2001) .
Pocket proteins and chromatin remodeling: a dynamic network controlling gene expression
Transcription in eukaryotic cells is strongly influenced by the manner in which DNA is packaged. Recent studies have revealed that there are different types of protein complexes capable of altering chromatin, and these may act in a physiological context to modulate DNA accessibility (Vignali et al., 2000) . In addition, studies have shown that alteration in histones, chromatin-related proteins, and DNA methylation contribute to transcriptional silencing of specific genes in cancer, but the sequence of these events is not well understood. Two models have been offered to describe the molecular sequence leading to the establishment of epigenetic gene silencing. One model suggests that histone modifications are the primary initiating event in transient repression (Tamaru et al., 2003) . DNA methylation subsequently accumulates in the targeted CpG island, creating a heterochromatin environment to establish a heritable, long-term state of transcriptional silencing. However, a second model is that DNA methylation can actually specify unique histone codes for maintaining the silenced state of a gene (Stirzaker et al., 2004) .
Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. In this case, DNA methylation may precede histone modifications. Changes of nucleosome position and rate of remodeling may contribute to the different roles of chromatin remodeling enzymes in vivo. The stability of open or closed chromatin is dictated by reversible histone modification, which correlates with gene activation or repression. The core histone tails are susceptible to a variety of covalent modifications, including acetylation, methylation, phosphorylation and ubiquitination. Moreover, different studies collectively support the histone code hypothesis, which suggests that the presence of a given modification on histone tails may dictate or prevent the presence of a second modification elsewhere on the same histone (Strahl and Allis, 2000) . Nucleosome acetylation is thought to occur in a localized manner in response to the transcriptional status of genes. Moreover, acetylation is dynamic and continuous, even in the absence of transcription. This may be particularly relevant for maintenance programs, in which a locus dictates an appropriate level of acetylation through the regulated actions of opposing enzymatic activities (Morrison et al., 2002) . Recent observations have now shown that DNA methylation is also important for transcriptional silencing and that a specific chromatin structure involving methylated histones may be necessary for DNA methylation to occur. Therefore, it has been proposed that DNA methylation Pocket proteins: modulators of gene transcription M Macaluso et al and histone deacetylation and methylation might work together to establish a repressive chromatin environment and silence gene expression (Newell-Price et al., 2000) .
In 1998, three different groups described the association of pRb/p105 with histone deacetylase (HDAC1) (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . This essential finding explained, on the molecular level, how the pocket proteins are able to repress transcription. We and other authors have shown that pRb2/p130 and p107 bear the same ability to repress E2F activity through recruitment of HDAC1 (Stiegler et al., 1998; Iavarone and Massague, 1999; Ferreira et al., 1998 Ferreira et al., , 2001 .
Several mechanisms have been proposed to account for transcriptional repression by the Rb family proteins (Dunaief et al., 1994; Trouche et al., 1997; Ferreira et al., 2001) , and some of the proposed models stress the importance of chromatin structure in regulating transcriptional activity. Active repression by Rb family members could involve a mechanism by which condensed chromatin structure is enhanced through histone deacetylation and methylation. In fact, the Rb proteins have been shown to repress E2F-dependent transcription by recruiting HDAC1/2 and histone methyltransferase SUV39H1 (Vandel et al., 2001; Frolov and Dyson, 2004) . Chromatin immunoprecipitation analyses demonstrated that pocket proteins recruit type 1 HDACs, resulting in removal of acetyl groups from histones H3 and H4 and in a compacted structure of chromatin, which is refractory to transcription initiation Morrison et al., 2002; Rayman et al., 2002) . In addition, it has been reported that in late G1, pocket proteins repressor complexes dissociate from E2F-responsive promoters, whereas activating E2Fs bind such promoters restoring histone acetylation (Rayman et al., 2002; Taubert et al., 2004) . These data link the potential activities of HDACs, HATs and SUV39H1 to the transcriptional regulation of E2F-responsive genes in a physiological setting suggesting a link between Rb family members and chromatin-modifying enzymes. However, the studies focused largely on pRb1/ p105 and did not extensively explore the potential contribution of HDAC-E2Fs-SUV39H1 with pRb2/ p130 and p107. Even if, ChIP experiments have demostrated that the recruitment of HDAC to E2F-responsive promoter in mammalian cells depends on an intact E2F-binding site in the promoter and requires p107 or pRb2/p130 Rayman et al., 2002) .
Recently, our studies have suggested that pRb2/p130 might be involved in mechanisms of transcriptional repression by recruiting DNMT1, HDAC1 and other chromatin remodeling enzymes (La Sala et al., 2003; Macaluso et al., 2003; Macaluso et al., 2005 Macaluso et al., , 2006 .
Conclusions and perspectives
Several lines of evidence indicate that pocket proteins and E2Fs govern the expression of many genes, through a complex network of interactions, including the association with chromatin modifying enzymes. Moreover, active repression by pRb family members could involve E2F-independent mechanisms. All this information open the important question: How exactly do pockets proteins control the expression of different genes, in different cell cycle stages and in different contexts? Further studies are necessary to characterize the components of this complex scenario of signals governing the association of specific pocket proteins with specific E2Fs as well as with specific chromatin modifying enzymes, and to understand the significance of these interactions in cell cycle control and differentiation.
